Ritch Geitenbeek
Papers
12
Total Citations
86
H-Index
5
About
Ritch Geitenbeek is a leading colorectal surgery researcher whose work is reshaping how we understand and optimize surgical treatment for rectal cancer. His research centers on comparing the four major total mesorectal excision (TME) techniques—open, laparoscopic, robot-assisted, and transanal—with a particular focus on functional outcomes, quality of life, and cost-effectiveness. Geitenbeek’s major contributions include demonstrating that minimally invasive approaches may reduce permanent stoma rates, as shown in his highly cited 2023 retrospective cohort study (24 citations). He has also led comprehensive meta-analyses evaluating how different TME techniques impact patients’ bowel, urinary, and sexual function, providing crucial evidence for surgical decision-making. His work extends to health economics, with systematic reviews comparing the costs of each technique (10 citations). Geitenbeek is the driving force behind the VANTAGE trial, a prospective multicenter observational study in the Netherlands, and the EUREKA collaborative, an international consortium evaluating robotic rectal cancer surgery. His recent 2025 RESOLUTION study offers ten-year comparative data on robot-assisted versus laparoscopic TME, cementing his role as a key voice in evidence-based colorectal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10